Birgitta Stellan

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Evren Alici, Tolga Sütlü, Bo Björkstrand et al. · Blood · 2008 · 195 citations · Full text

Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy

Tolga Sütlü, Sanna Nyström, Mari Gilljam et al. · Human Gene Therapy · 2012 · 152 citations

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

Tolga Sütlü, Birgitta Stellan, Mari Gilljam et al. · Cytotherapy · 2010 · 125 citations

Vaccination, Cell Therapy, Immunology +10

A Novel Human CCAAT/Enhancer Binding Protein Gene, C/EBPϵ, Is Expressed in Cells of Lymphoid and Myeloid Lineages and Is Localized on Chromosome 14q11.2 Close to the T-Cell Receptor α/δ Locus

Per Antonson, Birgitta Stellan, Ryuya Yamanaka et al. · Genomics · 1996 · 110 citations

Immunogenetics, Lymphocyte Development, Immune Cell Development +9

Safety Analysis of <i>Ex Vivo</i> -Expanded NK and NK-Like T Cells Administered to Cancer Patients: a Phase I Clinical Study

Lisbeth Barkholt, Evren Alici, Réka Conrad et al. · Immunotherapy · 2009 · 110 citations